免疫组化技术在肿瘤病理诊断中的应用价值  

Application value of immunohistochemistry technology in tumor pathological diagnosis

作　　者：席芳 XI Fang(Pathology Department,Jiyuan Maternal and Child Health Hospital,Jiyuan,Henan 459000,China)

机构地区：[1]济源市妇幼保健院病理科,河南济源459000

出　　处：《中国医学工程》2024年第2期90-93,共4页China Medical Engineering

摘　　要：目的研究免疫组化技术对肿瘤病理诊断中的诊断意义。方法选取2020年6月至2022年6月济源市妇幼保健院收治的100例疑似肿瘤患者进行前瞻性研究,均行常规技术、免疫组化技术。以手术病理结果为金标准,计算常规技术、免疫组化技术的诊断效能,并运用SPSS软件进行对比。结果100例疑似肿瘤患者中,72例经手术病理检查确诊为肿瘤。免疫组化技术检查的敏感性、特异性及准确性分别为97.22%、96.43%、97.00%,高于常规技术的77.78%、71.43%、76.00%(P<0.05)。结论免疫组化技术在肿瘤病理诊断中,具有较高的临床价值。【Objective】To study the clinical significance of immunohistochemistry technology in tumor pathological diagnosis.【Methods】One hundred suspected tumor patients admitted in Jiyuan Maternal and Child Health Hospital from June 2020 to June 2022 were studied by conventional techniques and immunohistochemistry.With the pathological results of surgery as the gold standard,the diagnostic efficacy of patients with these two examination techniques was calculated,and SPSS software was used for comparison.【Results】Of the 100 patients with suspected tumor,72 patients were diagnosed as tumor by surgical pathological examination.The sensitivity,specificity and accuracy of immunohistochemistry were 97.22%,96.43%and 97.00%,respectively,higher than 77.78%,71.43%and 76.00%of conventional techniques(P<0.05).【Conclusion】Immunohistochemical technology has high clinical value in tumor pathological diagnosis.

关 键 词：免疫组化技术 肿瘤 病理诊断 

分 类 号：R730.43[医药卫生—肿瘤]